97070 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Albumins
Sub-classes:PREPARATION OF BIOLOGICALLY ACTIVE COMPLEXES
#2RECOMBINANT ENGINEERING BACTERIUM FOR IMPROVING YIELD OF RECOMBINANT HUMAN ALBUMIN
#3IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES
#4Methods of Treating PD-L1 Expressing Cancer
#5COMPOSITIONS FOR TREATING ECTOPIC CALCIFICATION DISORDERS, AND METHODS USING SAME
#6ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME
#7ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF
#8CELL CULTURE MEDIA CONTAINING COMBINATIONS OF PROTEINS
#9COLLOIDALLY STABLE HEME-ALBUMIN COMPLEXES AND METHODS OF MAKING AND USING THEREOF
#10CURCUMIN-PEPTIDE CONJUGATES AND FORMULATIONS THEREOF
#11THERAPEUTIC USE OF P75NTR NEUROTROPHIN BINDING PROTEIN
#12ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES
#13IMPROVED MEDIA FOR THE EXPRESSION OF RECOMBINANT VITAMIN K-DEPENDENT PROTEINS
#14CONJUGATION OF LIPOPHILIC ALBUMIN-BINDING MOIETY TO RNA FOR IMPROVED CARRIER-FREE IN VIVO PHARMACOKINETICS AND GENE SILENCING
#15Lactose And Human Milk Oligosaccharides (HMOS) Production In Cells
#16SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#17COMPLEMENT FACTOR I-RELATED COMPOSITIONS AND METHODS
#18CLINICAL ASSESSMENT OF M-PROTEIN RESPONSE IN MULTIPLE MYELOMA
#19FUSION PROTEIN BETWEEN SHORT FORM ROD-DERIVED CONE VIABILITY FACTOR AND A HYDROPHILIC PEPTIDE
#20DNASE1-LIKE 3 AND ITS USE IN THERAPY
#21ANIMAL FREE- ALPHA-LACTALBUMIN AND BETA-LACTOGLOBULIN FUSION MILK PROTEINS AND A PROCESS FOR PREPARING THE SAME
#22ALBUMIN BINDING DOMAIN FUSION PROTEINS
#23Compositions and Methods for Killing PD-1 Positive Cells
#24BINDING AGENTS
#25Polymer of Protein-Conjugated Polysaccharide, Preparation Method Therefor, Enzyme-Stabilizing Composition Comprising Same, and Method for Detecting Target Nucleic Acid Molecule by Using Same
#26PLANT CELL LINE FOR PRODUCING ALBUMIN AT HIGH EFFICIENCY AND USE THEREOF
#27ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY
#28AMINO ACID SEQUENCES THAT MODULATE THE INTERACTION BETWEEN CELLS OF THE IMMUNE SYSTEM
#29COMPOSITIONS AND METHODS RELATED TO IMMUNOGLOBULIN PROTEASES AND FUSIONS THEREOF
#30SERUM ALBUMIN-BASED FUSION PROTEIN, AND NANO-ASSEMBLY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#31ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF
#32PROTEIN ISOLATE
#33CHEESE FOOD COMPOSITIONS
#34METHOD FOR PRODUCING BIRD PRODUCING HUMAN IMMUNOGLOBULIN FC AND TARGET PROTEIN
#35ULINASTATIN POLYPEPTIDES
#36VIRAL VECTOR ENCODING GLP-1 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING METABOLIC DISEASES IN FELINES
#37METHOD FOR PREPARING A CONDITIONALLY ACTIVE ANTIBODY OR ANTIBODY FRAGMENT
#38COMPOSITIONS COMPRISING A CASEIN AND METHODS OF PRODUCING THE SAME
#39Fusion proteins for the diagnosis, prophylaxis and treatment of infectious diseases
#40RECOMBINANT FACTOR VIII PROTEINS
#41ALBUMIN BINDING PEPTIDE CONJUGATES AND METHODS THEREOF
#42Method of using a genetically modified mouse that expresses human albumin
#43Compositions for treating ectopic calcification disorders, and methods using same
#44CLINICAL ASSESSMENT OF M-PROTEIN RESPONSE IN MULTIPLE MYELOMA
#45METHOD FOR POLISHING ALBUMIN
#46IL-10 AND USES THEREOF
#47IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES
#48TARGETED PROTEIN CONTRAST AGENTS, METHODS OF MAKING, AND USES THEREOF
#49Protein-based films
#50Compositions and methods for increasing the efficiency of cell cultures used for food production
#51COMPOSITIONS AND METHODS FOR INCREASING THE EFFICIENCY OF CELL CULTURES USED FOR FOOD PRODUCTION
#52METHODS OF TREATING PD-L1 EXPRESSING CANCER
#53Cell culture media containing combinations of proteins
#54AAV-ZYME AND USE FOR INFUSION REPLACEMENT THERAPY
#55ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES
#56Activatable fusion protein and use thereof
#57ULINASTATIN POLYPEPTIDES FOR TREATING DISEASES
#58Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing
#59COMPOSITION AND METHOD FOR CRYOPRESERVATION OF CELLS
#60REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
#61RECOMBINANT MILK PROTEINS AND COMPOSITIONS COMPRISING THE SAME
#62ALBUMIN BINDING ANTIBODIES AND USE THEREOF
#63Engineering of DNASE enzymes for manufacturing and therapy
#64Compositions comprising a casein and methods of producing the same
#65Albumin binding domain fusion proteins
#66Engineered human extracellular DNASE enzymes
#67Methods and reagents for modulating macrophage phenotype
#68Conditionally active polypeptides and methods of generating them
#69New Tools for Improving Gene Therapy and Use Thereof
#70PROTOXIN-II VARIANTS AND METHODS OF USE
#71MACROPINOCYTOSIS IN CANCER
#72Compositions and methods for increasing the efficiency of cell cultures used for food production
#73Albumin binding peptide conjugates and methods thereof
#74Method for producing active form of long-acting insulin analogue derivative using clostripain
#75METHODS OF USING DNASE1-LIKE 3 IN THERAPY
#76CULTURE MEDIUM FOR ASSISTED REPRODUCTIVE TECHNOLOGY
#77Ulinastatin polypeptides
#78Nucleic acid molecules encoding activin receptor type IIA variants
#79Regulatory T cell epitopes, compositions and uses thereof
#80Regulatory T cell epitopes, compositions and uses thereof
#81MILK PROTEIN PRODUCTION IN TRANSGENIC PLANTS
#82Cell culture media containing combinations of proteins
#83Engineering of DNASE enzymes for manufacturing and therapy
#84MODIFIED RNA WITH DECREASED IMMUNOSTIMULATORY PROPERTIES
#85Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide
#86Amino acid sequences that modulate the interaction between cells of the immune system
#87Methods of treating PD-L1 expressing cancer
#88PREPARATION OF BIOLOGICALLY ACTIVE COMPLEXES
#89Therapeutic protein compositions and methods
#90Nucleic acids encoding p75NTR neurotrophin binding proteins
#91Targeted protein contrast agents, methods of making, and uses thereof
#92COMPOSITIONS COMPRISING A CASEIN AND METHODS OF PRODUCING THE SAME
#93COMPOSITIONS COMPRISING A CASEIN AND METHODS OF PRODUCING THE SAME
#94Compositions for Treating Ectopic Calcification Disorders, and Methods Using Same
#95Serpin fusion polypeptides and methods of use thereof
#96Factor IX polypeptides and methods of use thereof
#97FOOD COMPOSITIONS COMPRISING MILK PROTEINS PRODUCED IN TRANSGENIC PLANTS
#98Methods and Materials for Producing Hybrid Cell Lines
#99MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS
#100FACTOR IX POLYPEPTIDES AND METHODS OF USE THEREOF
#101Serpin fusion polypeptides and methods of use thereof
#102IL-22BP COMPOSITIONS AND METHOD FOR THE TREATMENT OF DISEASE THEREWITH
#103Curcumin-peptide conjugates and formulations thereof
#104Targeted protein contrast agents, methods of making, and uses thereof
#105Protein isolate and process for the production thereof
#106Albumin variants and conjugates
#107Genetically modified mouse that expresses human albumin
#108Methods of using DNASE1-like 3 in therapy
#109Cell culture media containing combinations of proteins
#110METHOD FOR POLISHING ALBUMIN
#111Agents and methods for diagnosing fish allergy
#112Conditionally active polypeptides and methods of generating them
#113Composition and Application of Arginine-depleting Agents for Cancer, Obesity, Metabolic Disorders, and Related Complications and Comorbidities
#114Human coagulation factor IX (FIX) fusion protein, preparation method therefor, and use thereof
#115PREPARATION OF BIOLOGICALLY ACTIVE COMPLEXES
#116Therapy using a factor XII inhibitor in a neurotraumatic disorder
#117MILK PROTEIN PRODUCTION IN TRANSGENIC PLANTS
#118Manufacturing and engineering of DNASE enzymes for therapy
#119SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#120Methods for treatment of nephrotic syndrome and related conditions
#121PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITY
#122Binding agents
#123Recombinant factor VIII proteins
#124Method for producing Wnt protein and method for storing Wnt protein
#125Multivalent heteromultimer scaffold design and constructs
#126IMMUNE SYSTEM MODULATORS
#127Method for efficient purification of human serum albumin
#128REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
#129Activin receptor type IIA variants and methods of use thereof
#130Methods and reagents for modulating macrophage phenotype
#131EPITHELIAL TUMOR CELL CULTURES
#132Activin receptor type IIa variants and methods of use thereof
#133Amino acid sequences that modulate the interaction between cells of the immune system
#134Adsorbent material
#135Combination with albumin, in particular for treating a cartilage defect
#136Factor IX polypeptides and methods of use thereof
#137Factor IX polypeptides and methods of use thereof
#138Regulatory T cell epitopes, compositions and uses thereof
#139Regulatory T cell epitopes, compositions and uses thereof
#140Pharmaceutical Compositions
#141Soluble glycoprotein V for treating thrombotic diseases
#142Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide
#143Measurement of glycoprotein
#144Measurement of glycoprotein
#145Multivalent heteromultimer scaffold design and constructs
#146Clinical assessment of M-protein response in multiple myeloma
#147Protein-surfactant-monomer/polymer blends and copolymers for protein-based plastics
#148IL-2 superagonists in combination with anti-PD-1 antibodies
#149Albumin binding peptide conjugates and methods thereof
#150Regulatory T cell epitopes, compositions and uses thereof
#151Regulatory T cell epitopes, compositions and uses thereof
#152Albumin binding domain fusion proteins
#153Mutated von Willebrand factor
#154Compositions for Treating Ectopic Calcification Disorders, and Methods Using Same
#155Pharmaceutical Compositions
#156Media for the expression of recombinant vitamin K-dependent proteins
#157Recombinant human C1 esterase inhibitor and uses thereof
#158Engineered primate cystine/cysteine degrading enzymes for therapeutic uses
#159High purity alpha lactalbumin and methods of making
#160MILK PROTEIN PRODUCTION IN TRANSGENIC PLANTS
#161Regulatory T cell epitopes, compositions and uses thereof
#162Regulatory T cell epitopes, compositions and uses thereof
#163Regulatory T cell epitopes, compositions and uses thereof
#164Regulatory T cell epitopes, compositions and uses thereof
#165Regulatory T cell epitopes, compositions and uses thereof
#166Regulatory T cell epitopes, compositions and uses thereof
#167Regulatory T cell epitopes, compositions and uses thereof
#168SIZE-SELECTIVE HEMOCOMPATIBLE POLYMER SYSTEM
#169Targeted protein contrast agents, methods of making, and uses thereof
#170Compositions comprising a casein and methods of producing the same
#171IL-22BP COMPOSITIONS AND METHOD FOR THE TREATMENT OF DISEASE THEREWITH
#172Factor IX Polypeptides and Methods of Use Thereof
#173Factor IX polypeptides and methods of use thereof
#174Factor IX Polypeptides and Methods of Use Thereof
#175ALBUMIN FUSION PROTEINS
#176Serpin fusion polypeptides and methods of use thereof
#177Composition for treating hyperlipidemia comprising oxyntomodulin derivative
#178Therapeutic use of p75NTR neurotrophin binding protein
#179Method for inactivation/removal of coagulation factors by precipitation
#180Long-lived polynucleotide molecules
#181Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing
#182Pharmaceutical Composition
#183Recombinant Phe-free proteins for use in the treatment of phenylketonuria
#184Fusion Protein Comprising Leptin and Methods for Producing and Using the Same
#185Method for efficient purification of human serum albumin
#186Chromatography device and method for filtering a solute from a fluid
#187Chloroplast Expressing Colostrum or Milk Polypeptides
#188Protoxin-II variants and methods of use
#189METHOD FOR SEPARATING ALPHA-LACTALBUMIN AND BETA-LACTOGLOBULIN
#190MODIFIED PROTEIN MATERIALS, METHODS AND USES THEREOF
#191Immune system modulators
#192Compositions comprising a casein and methods of producing the same
#193Biofabrication techniques for the implementation of intrinsic tissue geometries to an in vitro collagen hydrogel
#194Phosphorylcholine group-containing compound and phosphorylcholine complex
#195PROCESS OF AFOD AND AFCC AND MANUFACTURING AND PURIFICATION PROCESSES OF PROTEINS
#196Multivalent heteromultimer scaffold design and constructs
#197Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing the same
#198THERAPY USING A FACTOR XII INHIBITOR IN A NEUROTRAUMATIC DISORDER
#199Factor VIII Fusion Protein
#200Colostrum/milk protein compositions
#201Administrable microparticles in vivo through medical conduit
#202Recombinant factor VIII proteins
#203Methods for treatment of nephrotic syndrome and related conditions
#204FUSION PROTEINS COMPRISING FACTOR IX FOR PROPHYLACTIC TREATMENT OF HEMOPHILIA AND METHODS THEREOF
#205Factor IX polypeptides and methods of use thereof
#206Hypericin albumin nanoparticle-serum antibody complex and preperation method and application thereof
#207RECOMBINANT FACTOR VIII PROTEINS
#208Engineered albumin binding polypeptide
#209Immune system modulators
#210Amino acid sequences that modulate the interaction between cells of the immune system
#211Method to concentrate von willebrand factor or complexes thereof
#212Amino acid sequences that modulate the interaction between cells of the immune system
#213Factor IX polypeptides and methods of use thereof
#214Chloroplast expressing colostrum or milk polypeptides
#215PROTOXIN-II VARIANTS AND METHODS OF USE
#216Factor IX polypeptides and methods of use thereof
#217Modified RNA with decreased immunostimulatory properties
#218Multivalent heteromultimer scaffold design and constructs
#219METHODS AND COMPOSITIONS RELATED TO LARGE SCALE PRODUCTION OF PROTEINS
#220Fusion protein comprising albumin and retinol-binding protein
#221Composition for treating hyperlipidemia comprising oxyntomodulin derivative
#222METHOD FOR PREPARING LOW ANTIGENIC FOOD AND LOW ANTIGENIC FOOD PREPARED BY SAID METHOD
#223Methods for isolating antibodies that bind sclerostin
#224Factor IX polypeptides and methods of use thereof
#225LONG-LIVED POLYNUCLEOTIDE MOLECULES
#226PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITY
#227Process for isolation of plasma or serum proteins
#228Regulatory T cell epitopes, compositions and uses thereof
#229METHODS FOR ISOLATING BLOOD PRODUCTS FROM AN INTER-ALPHA INHIBITOR PROTEIN-DEPLETED BLOOD PRODUCT MATERIAL
#230Biologically active complex and its preparation
#231Curcumin-peptide conjugates and formulations thereof
#232Spider silk fusion protein structures for binding to an organic target
#233Nucleotide sequence and a process thereof
#234COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVE
#235Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing the same
#236Serpin fusion polypeptides and methods of use thereof
#237Process for the purification of recombinant albumin
#238Therapeutic use of p75NTR neurotrophin binding protein
#239Methods of treating cancer with low density lipoprotein-related protein 6 (LRP6)—half life extender constructs
#240METHOD FOR PRODUCING MILK PROTEIN NANOPARTICLES
#241MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE
#242Plasma protein fractionation by sequential polyacid precipitation
#243ALBUMIN FUSION PROTEINS
#244IL-2 derivative polypeptides
#245Albumin formulation and use
#246Long acting biologically active luteinizing hormone (LH) compound
#247Thixotropic α-lactalbumin hydrogels, method for preparing same and uses thereof
#248METHODS FOR ISOLATING BLOOD PRODUCTS FROM AN INTER-ALPHA INHIBITOR PROTEIN-DEPLETED BLOOD PRODUCT MATERIAL
#249Methods for treatment of nephrotic syndrome and related conditions
#250Whey protein hydrolysate containing tryptophan peptide consisting of alpha lactalbumin and the use thereof
#251Caprylate viral deactivation
#252SEQUENCE OF 55 NEW FOUND PROTEINS AND THEIR APPLICATION
#253HYPOALLERGENIC MUTANT POLYPEPTIDES BASED ON FISH PARVALBUMIN
#254METHOD FOR IMMOBILIZING ALBUMIN ON A SELF-ASSEMBLED MONOLAYER
#255Factor VIII, von Willebrand factor or complexes thereof with prolonged in vivo half-life
#256Multivalent heteromultimer scaffold design and constructs
#257Biologically active complex and its preparation
#258METHOD FOR POLISHING ALBUMIN
#259Treatment with factor ix-albumin fusion protein
#260Method for inactivation/removal of coagulation factors by precipitation
#261Treatment with factor VII-albumin fusion protein
#262Fusion protein comprising albumin and retinol-binding protein
#263Serpin fusion polypeptides and methods of purification thereof
#264Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
#265Albumin Fusion Proteins
#266PEGYLATED ALBUMIN POLYMERS AND USES THEREOF
#267Albumin Variants
#268Factor IX polypeptides and methods of use thereof
#269USE OF G-CSF DIMER IN THE TREATMENT OF NEUTROPENIA
#270AMINO ACID SEQUENCES OF NANOBODIES DIRECTED AGAINST P19 SUBUNIT OF THE HETERODIMERIC CYTOKINE IL-23
#271ALBUMIN FUSION PROTEINS
#272Factor VIII fusion protein
#273ALBUMIN FUSION PROTEINS
#274Serpin fusion polypeptides and methods of use thereof
#275Cell Culture Media Containing Combinations of Proteins
#276Interleukin-11 Fusion Proteins
#277ALBUMIN FUSION PROTEINS
#278Multivalent heteromultimer scaffold design and constructs
#279Albumin fusion proteins
#280Albumin Fusion Proteins
#281Disrupting FCRN-albumin interactions
#282LONG LASTING FUSION PEPTIDE INHIBITORS FOR HIV INFECTION
#283Complex and production process
#284METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES
#285Albumin variants and conjugates
#286PROCESS FOR THE PRODUCTION OF PREFORMED CONJUGATES OF ALBUMIN AND A THERAPEUTIC AGENT
#287Process for the purification of recombinant albumin
#288Albumin Fusion Proteins
#289Whey Protein Hydrolysate Containing Tryptophan Peptide Consisting of Alpha Lactalbumin and the Use Thereof
#290AMINO ACID SEQUENCES THAT MODULATE THE INTERACTION BETWEEN CELLS OF THE IMMUNE SYSTEM
#291PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITY
#292Factor VIII, von willebrand factor or complexes thereof with prolonged in vivo half-life
#293REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
#294Conversion coating for aluminum and its alloys and articles thereof
#295Polynucleotide encoding a sclerostin-binding antibody
#296Recombinant albumins fused with poly-cysteine peptide and the methods for preparing the same
#297Hypoallergenic Mutant Polypeptides Based on Fish Parvalbumin
#298Albumin Fusion Proteins
#299Peptide standards
#300Interleukin-11 Fusion Proteins